Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia
Only 14 percent of hospitals that referred patients with acute promyelocytic leukemia had ATRA readily available
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.